Taqman SNP Genotyping Assays, developed by Applied Biosystems, are a state-of-the-art technology for screening and validation of polymorphisms. Recently Applied Biosystems introduced two new products to complement this offering; the high throughput Taqman Open Array Genotyping System and Taqman Copy Number Assays.
Andreas Persidis of Biovista talks to NGP about the transformational potential of drug repositioning.
Sati Sian of IMS Health looks at how pharmaceutical companies are reviewing their strategies to meet changing market needs.